The Ensign Group, Inc. adopted amended and restated bylaws to align with Delaware law developments and clarify Board powers. The updates revise procedural mechanics for stockholder nominations and proposals, including notice timeframes of 90 to 120 days prior to the annual meeting anniversary. Director candidates must now be available for Board interviews. These changes became effective immediately upon approval on August 20, 2026. For the 2027 Annual Meeting, written notices for director nominations or proposals must be received between January 13, 2027, and February 12, 2027. The company operates in the healthcare industry, specifically providing post-acute care services.
